• 1
    Bytzer P, Hansen JM, Havelund T, Malchow-Moller A. Schaffalitzky de Muckadell OB. Predicting endoscopic diagnosis in the dyspeptic patient: the value of clinical judgement. Eur J Gastroenterol Hepatol 1996; 8: 35963.
  • 2
    Hansen JM, Bytzer P. Schaffalitzky de Muckadell OB. Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping. Scand J Gastroenterol 1998; 3: 799805.
  • 3
    Heikkinen M, Pikkarainen P, Eskelinen M, Julkunen R. GPs' ability to diagnose dyspepsia based only on physical examination and patient history. Scand J Prim Health Care 2000; 18: 99104.
  • 4
    Kagevi I, Löfstedt S, Persson L-G. Endoscopic findings and diagnoses in unselected dyspeptic patients at a primary health care center. Scand J Gastroenterol 1989; 24: 14550.
  • 5
    Klauser AG, Voderholzer WA, Knesewitsch PA, Schindlbeck NE, Muller-Lissner SA. What is behind dyspepsia? Dig Dis Sci 1993; 38: 14754.
  • 6
    Colin-Jones DG, Bloom B, Bodemar G, et al. Management of dyspepsia. Report of a working party. Lancet 1988; 1: 5769.
  • 7
    Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ III. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 125968.
  • 8
    Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993; 105: 137886.
  • 9
    Chiba N, Bernard L, O'Brien BJ, Goeree R, Hunt RH. A Canadian physician survey of dyspepsia management. Can J Gastroenterol 1998; 1: 8390.
  • 10
    Talley NJ, Colin-Jones D, Koch KL, et al. Functional dyspepsia: a classification with guidelines for diagnosis and management. Working team report. Gastroenterol Int 1991; 4: 14560.
  • 11
    Feldman RA, Deeks JJ, Evans SJW. Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Eur J Clin Microbiol Infect Dis 1995; 14: 42833.
  • 12
    Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ III Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990; 65: 145679.
  • 13
    Drossman DA, Thompson GW, Talley NJ, et al. Identification of sub-groups of functional gastrointestinal disorders. Working team report. Gastroenterol Int 1990; 3: 15972.
  • 14
    Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population. Overlap and lack of stability over time. Gastroenterology 1995; 109: 67180.
  • 15
    Westbrook JI, Talley NJ. Empiric clustering of dyspepsia into symptom subgroups: a population-based study. Scand J Gastroenterol 2002; 37: 91723.
  • 16
    Euler AR, Byrne WJ. Twenty-four-hour esophageal intraluminal pH probe testing: a comparative analysis. Gastroenterology 1981; 80: 95761.
  • 17
    Richter JE, Castell DO. Gastroesophageal reflux. Pathogenesis, diagnosis and therapy. Ann Intern Med 1982; 97: 93103.
  • 18
    Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996; 110: 198296.
  • 19
    Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Gut 1999; 45(Suppl. II): II37II42.
  • 20
    Agréus L, Svärdsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001; 96: 290514.
  • 21
    Weir RD, Backett EM. Studies of the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer. Gut 1968; 9: 7583.
  • 22
    Sloth H, Jørgensen LS. Chronic non-organic upper abdominal pain. diagnostic safety and prognosis of gastrointestinal and non-intestinal symptoms. A 5- to 7-year follow-up study. Scand J Gastroenterol 1988; 23: 127580.
  • 23
    Barnes RJ, Uff JS, Dent JC, Gear MW, Wilkinson SP. Long-term follow up of patients with gastritis associated with Helicobacter pylori infection. Br J General Pract 1991; 41: 2868.
  • 24
    Lindell GH, Celebioglu F, Graffer HO. Non-ulcer dyspepsia in the long-term perspective. Eur J Gastroenterol Hepatol 1995; 7: 82933.
  • 25
    Meineche-Schmidt V, Jørgensen T. Investigation and therapy in patients with different types of dyspepsia: a 3 year follow-up study from general practice. Fam Pract 2000; 17: 51421.
  • 26
    Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management – the Genval Workshop Report. Gut 1999; 44(Suppl. 2): S1S16.
  • 27
    Rekola KE, Keinänen-Kiukaanniemi S, Takala J. Use of primary health services in sparsely populated country districts by patients with musculoskeletal symptoms: consultations with a physician. J Epidemiol Community Health 1993; 47: 1537.
  • 28
    Hsu P-I, Lai K-H, Lo G-H, et al. Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients. Gut 2002; 51: 1520.
  • 29
    Talley NJ, Meineche-Schmidt V, Pare P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998; 12: 105565.
  • 30
    Schindlbeck NE, Klauser AG, Berghammer G, Londong W, Muller-Lissner SA. Three year follow up of patients with gastroesophageal reflux disease. Gut 1992; 33: 10169.
  • 31
    McDougall NI, Johnston BT, Kee F, et al. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996; 38: 4816.
  • 32
    Isolauri J, Luostarinen M, Isolauri E, et al. Natural course of gastroesophageal reflux disease: 17–22 year follow-up of 60 patients. Am J Gastroenterol 1997; 92: 3741.